Laboratory of Genome Integrity, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
CCR Collaborative Bioinformatics Resource, Office of Science and Technology Resources, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
J Exp Med. 2018 Jan 2;215(1):249-262. doi: 10.1084/jem.20170832. Epub 2017 Nov 28.
Early innate lymphoid progenitors (EILPs) have recently been identified in mouse adult bone marrow as a multipotential progenitor population specified toward innate lymphoid cell (ILC) lineages, but their relationship with other described ILC progenitors is still unclear. In this study, we examine the progenitor-successor relationships between EILPs, all-lymphoid progenitors (ALPs), and ILC precursors (ILCps). Functional, bioinformatic, phenotypical, and genetic approaches collectively establish EILPs as an intermediate progenitor between ALPs and ILCps. Our work additionally provides new candidate regulators of ILC development and clearly defines the stage of requirement of transcription factors key for early ILC development.
早期固有淋巴前体(EILP)最近在成年鼠骨髓中被鉴定为多能祖细胞群,其定向于固有淋巴细胞(ILC)谱系,但它们与其他描述的 ILC 祖细胞之间的关系仍不清楚。在这项研究中,我们研究了 EILP、全淋巴祖细胞(ALP)和 ILC 前体(ILCps)之间的祖细胞-后继细胞关系。功能、生物信息学、表型和遗传方法共同确立 EILP 为 ALP 和 ILCp 之间的中间祖细胞。我们的工作还提供了 ILC 发育的新候选调节剂,并明确定义了早期 ILC 发育所需转录因子的阶段要求。